(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-07 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 577380
Date | Daily Closing Price | Open | High | Low | Volume |
07 Mon Oct 2024 | 89.32 | 88.75 | 90.88 | 88.31 | 0.974 times |
04 Fri Oct 2024 | 88.61 | 89.08 | 89.89 | 88.10 | 0.537 times |
03 Thu Oct 2024 | 88.07 | 89.89 | 90.08 | 87.43 | 0.753 times |
02 Wed Oct 2024 | 90.76 | 89.49 | 91.08 | 88.84 | 1.065 times |
01 Tue Oct 2024 | 90.00 | 91.63 | 92.41 | 87.96 | 1.412 times |
30 Mon Sep 2024 | 92.50 | 92.33 | 92.73 | 89.51 | 1.137 times |
27 Fri Sep 2024 | 92.55 | 90.05 | 94.70 | 89.94 | 1.441 times |
26 Thu Sep 2024 | 89.06 | 88.68 | 89.15 | 87.16 | 0.687 times |
25 Wed Sep 2024 | 87.00 | 90.20 | 90.80 | 86.92 | 0.839 times |
24 Tue Sep 2024 | 90.27 | 89.87 | 90.98 | 89.18 | 0.754 times |
My analysis of stock is bullish for shortterm, and stock might move up till 91.2 or till 93.9. Use a stoploss of 88.93 and if this stock hits its stoploss, then it can fall down till 86.69
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 83.91 |
Downside Target | 85.64 |
Upside Target | 92.73 |
Upside Target | 93.66 |
Upside Target | 94.70 |
Upside Target | 96.50 |
Upside Target | 100.67 |
Upside Target | 106.56 |
Upside Target | 108.40 |
Upside Target | 111.42 |
Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 88.13 |
Downside Intraday Target | 86.93 |
Upside Intraday Target | 90.7 |
Upside Intraday Target | 92.07 |
Upside Intraday Target | 89.5 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
07 Mon Oct 2024 | 89.32 | 88.75 | 90.88 | 88.31 | 0.199 times |
04 Fri Oct 2024 | 88.61 | 92.33 | 92.73 | 87.43 | 0.963 times |
27 Fri Sep 2024 | 92.55 | 91.57 | 94.70 | 86.92 | 0.731 times |
20 Fri Sep 2024 | 91.68 | 89.11 | 93.66 | 85.64 | 1.237 times |
13 Fri Sep 2024 | 88.90 | 86.30 | 89.05 | 83.91 | 1.124 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
07 Mon Oct 2024 | 89.32 | 91.63 | 92.41 | 87.43 | 0.199 times |
30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 90.16 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 90.16 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.